Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.

    Siker Kimbung, Kovács, A., Johansson, I., Danielsson, A., Pär-Ola Bendahl, Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i11-i12

    Research output: Contribution to journalArticle

  2. 37p * androgen receptor expression in a population-based prospective breast cancer cohort.

    Karin Elebro, Signe Borgquist, Simonsson, M., Markkula, A., Rose, C., Christian Ingvar & Helena Jernström, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i13

    Research output: Contribution to journalPublished meeting abstract

  3. 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration

    Stuart, G., Avall-Lundqvist, E., du Bois, A., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., Eisenhauer, E., Friedlaender, M., Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Hogberg, T., Kaye, S., Kitchener, H., Kristensen, G., Mannel, R., Meier, W. & 21 others, Miller, B., Oza, A., Ozols, R., Parmar, M., Pfisterer, J., Poveda, A., Provencher, D., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G., Sagae, S., Stehman, F., Trimble, E., Thigpen, T., Vasey, P., Vergote, I., Verheijen, R., Vermorken, J. & Wagner, U., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16, Suppl 8, p. viii36-viii38

    Research output: Contribution to journalArticle

  4. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

  5. Adjuvant therapy in primary GIST: state-of-the-art

    Reichardt, P., Blay, J. -Y., Boukovinas, I., Brodowicz, T., Broto, J. M., Casali, P. G., Decatris, M., Mikael Eriksson, Gelderblom, H., Kosmidis, P., Le Cesne, A., Pousa, A. L., Schlemmer, M., Verweij, J. & Joensuu, H., 2012, In : Annals of Oncology. 23, 11, p. 2776-2781

    Research output: Contribution to journalReview article

  6. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  7. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

    Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J. -O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D. & Ringden, O., 2006, In : Annals of Oncology. 17, 7, p. 1134-1140

    Research output: Contribution to journalArticle

  8. a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma

    Dueland, S., Aamdal, S., Nyakas, M., Lundgren, L., Wagenius, G., Ljuslinder, I., Stierner, U., Gaullier, J., Nilsson, B. I. & Rasch, W., 2008, In : Annals of Oncology. 19, p. 245-246

    Research output: Contribution to journalPublished meeting abstract

  9. Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer

    Loughman, T., Chan-Ju Wang, A., Dynoodt, P., Fender, B., Lopez Ruiz, C., Barron, S., Stapleton, S., O'Leary, D., Fabre, A., Quinn, C., B. Nodin, K. Jirstrom, Bracken, A. & Gallagher, W. M., 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, p. viii65

    Research output: Contribution to journalArticle

  10. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

    Ferreri, AJM., Campo, E., Arnbrosetti, A., Ilariucci, F., Seymour, JF., Willemze, R., Arrigoni, G., Rossi, G., Lopez-Guillermo, A., Berti, E., Eriksson, M., Federico, M., Cortelazzo, S., Govi, S., Frungillo, N., Dell'Oro, S., Lestani, M., Asioli, S., Pedrinis, E., Ungari, M. & 7 others, Motta, T., Rossi, R., Artusi, T., Iuzzolino, P., Zucca, E., Cavalli, F. & Ponzoni, M., 2004, In : Annals of Oncology. 15, 8, p. 1215-1221

    Research output: Contribution to journalArticle

  11. A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

    Glimelius, B., Sorbye, H., Balteskard, L., Bystrom, P., Pfeiffer, P., Tveit, K., Heikkila, R., Keldsen, N., Albertsson, M., Starkhammar, H., Garmo, H. & Berglund, A., 2008, In : Annals of Oncology. 19, 5, p. 909-914

    Research output: Contribution to journalArticle

  12. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

    Anders Johnsson, Helga Hagman, Frödin, J-E., Berglund, Å., Keldsen, N., Fernebro, E., Sundberg, J., De Pont Christensen, R., Garm Spindler, K-L., Bergström, D. & Jakobsen, A., 2013, In : Annals of Oncology. 24, 9, p. 2335-2341

    Research output: Contribution to journalArticle

  13. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

    Helga Hagman, Frödin, J-E., Berglund, Å., Sundberg, J., Vestermark, L., Albertsson, M., Fernebro, E. & Anders Johnsson, 2016 Jan, In : Annals of Oncology. 27, 1, p. 140-147

    Research output: Contribution to journalArticle

  14. Autoimmune disease and subsequent digestive tract cancer by histology

    Kari Hemminki, Liu, X., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2012, In : Annals of Oncology. 23, 4, p. 927-U6

    Research output: Contribution to journalArticle

  15. BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M., Banham, A., Enblad, G. & Leppa, S., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 142-iv 142

    Research output: Contribution to journalPublished meeting abstract

  16. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M. & 32 others, Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., ESMO Guidelines Committee & PaedCan, 2018, In : Annals of Oncology. 29, p. iv79-iv95

    Research output: Contribution to journalArticle

  17. Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

    Mikael Eriksson & The ESMO/European Sarcoma Network Working Group, 2014, In : Annals of Oncology. 25, p. iii113-iii123

    Research output: Contribution to journalArticle

  18. Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries

    Brown, P. D., Samuelsson, V., d'Amore, F., Lindh, J., Hagberg, H., Nilsson, G., Bernell, P., Pedersen, L. M. & Mats Jerkeman, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 131-iv 131

    Research output: Contribution to journalPublished meeting abstract

  19. Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.

    Boniol, M., Koechlin, A., Świątkowska, B., Sorahan, T., Wellmann, J., Taeger, D., Jakobsson, K., Pira, E., Boffetta, P., La Vecchia, C., Pizot, C. & Boyle, P., 2016, In : Annals of Oncology. 27, 5, p. 933-941

    Research output: Contribution to journalArticle

  20. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

    Kari Hemminki, Bevier, M., Jan Sundquist & Hemminki, A., 2012, In : Annals of Oncology. 23, 10, p. 2720-2724

    Research output: Contribution to journalArticle

  21. Cancer prevalence in European registry areas

    Micheli, A., Mugno, E., Krogh, V., Quinn, M. J., Coleman, M., Hakulinen, T., Gatta, G., Berrino, F., Capocaccia, R., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 840-865

    Research output: Contribution to journalArticle

  22. Cancer prevalence in Northern Europe: the EUROPREVAL study.

    Möller, T., Anderson, H., Aareleid, T., Hakulinen, T., Storm, H., Tryggvadottir, L., Corazziari, I. & Mugno, E., 2003, In : Annals of Oncology. 14, 6, p. 946-957

    Research output: Contribution to journalArticle

  23. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden

    J. Ji, Shu, X., Li, X., Kristina Sundquist, Sundquist, J. & Hemminki, K., 2009, In : Annals of Oncology. 20, 6, p. 1121-1126

    Research output: Contribution to journalArticle

  24. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

    Bjoerkholm, M., Hagberg, H., Holte, H., Kvaloy, S., Teerenhovi, L., Anderson, H., Cavallin-Ståhl, E., Myhre, J., Pertovaara, H., Oest, A., Nilsson, B. & Oesby, E., 2007, In : Annals of Oncology. 18, 6, p. 1085-1089

    Research output: Contribution to journalArticle

  25. Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours

    Blay, J., Le Cesne, A., Judson, I., Schoffski, P., Sessa, C., Paz-Ares, L., Thomas Högberg, Zintl, P., Parekh, T. V. & Demetri, G. D., 2010, In : Annals of Oncology. 21, Suppl. 8, p. 177-178

    Research output: Contribution to journalPublished meeting abstract

  26. CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial

    Mats Jerkeman, Anderson, H., Cavallin-Ståhl, E., Michael Dictor, Hagberg, H., Johnson, A., Kaasa, S., Kvaloy, S., Sundstrom, C. & Åkerman, M., 1999, In : Annals of Oncology. 10, 9, p. 1079-1086

    Research output: Contribution to journalArticle

  27. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Hochhaus, A., Saussele, S., Rosti, G., Mahon, F-X., Janssen, J. J. W. M., Hjorth-Hansen, H., J. Richter, Buske, C. & ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv41-iv51

    Research output: Contribution to journalArticle

  28. Clinical trials in ovarian carcinoma: study methodology

    Vermorken, J. B., Parmar, M. K. B., Brady, M. F., Eisenhauer, E. A., T Hogberg, Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S. & Verheijen, R. H. M., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16 , Suppl 8, p. viii20-viii29

    Research output: Contribution to journalArticle

  29. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Schmitz, N., Zeynalova, S., Glass, B., Kaiser, U., Cavallin-Ståhl, E., Wolf, M., Haenel, M., Loeffler, M., Truemper, L. & Pfreundschuh, M., 2012, In : Annals of Oncology. 23, 5, p. 1267-1273

    Research output: Contribution to journalArticle

  30. Colon cancer prevalence and estimation of differing care needs of colon cancer patients

    Gatta, G., Capocaccia, R., Berrino, F., Ruzza, M. R., Contiero, P., Möller, T. & EUROPREVAL Working Group, A. T., 2004, In : Annals of Oncology. 15, 7, p. 1136-1142

    Research output: Contribution to journalArticle

  31. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation

    Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Saeter, G. & Thor Alvegård, 2001, In : Annals of Oncology. 12, 11, p. 1601-1604

    Research output: Contribution to journalArticle

  32. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Fedirko, V., Trichopolou, A., Bamia, C., Duarte-Salles, T., Trepo, E., Aleksandrova, K., Noethlings, U., Lukanova, A., Lagiou, P., Boffetta, P., Trichopoulos, D., Katzke, V. A., Overvad, K., Tjonneland, A., Hansen, L., Boutron-Ruault, M. C., Fagherazzi, G., Bastide, N., Panico, S., Grioni, S. & 24 others, Vineis, P., Palli, D., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H., Skeie, G., Engeset, D., Parr, C. L., Jakszyn, P., Sanchez, M. J., Barricarte, A., Amiano, P., Chirlaque, M., Quiros, J. R., Sund, M., Werner, M., Emily Sonestedt, Ulrika Ericson, Key, T. J., Khaw, K. T., Ferrari, P., Romieu, I., Riboli, E. & Jenab, M., 2013, In : Annals of Oncology. 24, 8, p. 2166-2173

    Research output: Contribution to journalArticle

  33. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

    Crusius, J. B. A., Canzian, F., Capella, G., Pena, A. S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H. B., Carneiro, F., Pala, V., Save, V. E., Vineis, P., Tumino, R., Panico, S., Berglund, G. & 27 others, Manjer, J., Stenling, R., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjonneland, A., Buechner, F. C., Peeters, P. H. M., Numans, M. E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E. & Gonzalez, C. A., 2008, In : Annals of Oncology. 19, 11, p. 1894-1902

    Research output: Contribution to journalArticle

  34. Death causes in breast cancer patients

    Riihimaeki, M., Thomsen, H., Brandt, A., Jan Sundquist & Kari Hemminki, 2012, In : Annals of Oncology. 23, 3, p. 604

    Research output: Contribution to journalArticle

  35. DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT

    Dolan, R. T., Brennan, D. J., Rexhepaj, E., Kelly, C. M., Penny, S., Karin Jirström, Ponten, F., Uhlen, M. & Gallagher, W. M., 2009, In : Annals of Oncology. 20, Suppl 2, p. 54-54

    Research output: Contribution to journalPublished meeting abstract

  36. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

    Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjonneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., Sieri, S. & 21 others, Sacerdote, C., Palli, D., Tumino, R., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quiros, J. R., Zamora-Ros, R., Sanchez, M. J., Arriola, L., Ardanaz, E., Tormo, M. J., Peter Nilsson, Lindkvist, B., Sund, M., Rolandsson, O., Khaw, K. T., Wareham, N., Travis, R. C., Riboli, E. & Noethlings, U., 2013, In : Annals of Oncology. 24, 9, p. 2449-2455

    Research output: Contribution to journalArticle

  37. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Obon-Santacana, M., Slimani, N., Lujan-Barroso, L., Travier, N., Hallmans, G., Freisling, H., Ferrari, P., Boutron-Ruault, M. C., Racine, A., Clavel, F., Saieva, C., Pala, V., Tumino, R., Mattiello, A., Vineis, P., Argueelles, M., Ardanaz, E., Amiano, P., Navarro, C., Sanchez, M. J. & 24 others, Montes, E. M., Key, T., Khaw, K. -T., Wareham, N., Peeters, P. H., Trichopoulou, A., Bamia, C., Trichopoulos, D., Boeing, H., Kaaks, R., Katzke, V., Ye, W., Sund, M., Ulrika Ericson, Elisabet Wirfält, Overvad, K., Tjonneland, A., Olsen, A., Skeie, G., Asli, L. A., Weiderpass, E., Riboli, E., Bueno-De-Mesquita, H. B. & Duell, E. J., 2013, In : Annals of Oncology. 24, 10, p. 2645-2651

    Research output: Contribution to journalArticle

  38. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

    Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. -L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Mats Jerkeman & Mikael Eriksson, 2013, In : Annals of Oncology. 24, 5, p. 1385-1392

    Research output: Contribution to journalArticle

  39. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

    Matikas, A., Foukakis, T., Moebus, V., Greil, R., Bengtsson, N. O., Steger, G. G., Untch, M., Johansson, H., Hellström, M., P. Malmström, Gnant, M., Loibl, S. & Bergh, J., 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 109-114 6 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next